You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Premarket Safety and Efficacy Studies for ADHD Medications in Children
|
---|---|
Published in |
PLOS ONE, July 2014
|
DOI | 10.1371/journal.pone.0102249 |
Pubmed ID | |
Authors |
Florence T. Bourgeois, Jeong Min Kim, Kenneth D. Mandl |
Abstract |
Attention-deficit hyperactivity disorder (ADHD) is a chronic condition and pharmacotherapy is the mainstay of treatment, with a variety of ADHD medications available to patients. However, it is unclear to what extent the long-term safety and efficacy of ADHD drugs have been evaluated prior to their market authorization. We aimed to quantify the number of participants studied and their length of exposure in ADHD drug trials prior to marketing. |
X Demographics
The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 23% |
United Kingdom | 3 | 10% |
Netherlands | 1 | 3% |
Spain | 1 | 3% |
Australia | 1 | 3% |
Unknown | 18 | 58% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 24 | 77% |
Practitioners (doctors, other healthcare professionals) | 4 | 13% |
Scientists | 3 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 2% |
United States | 1 | 2% |
Netherlands | 1 | 2% |
Germany | 1 | 2% |
Unknown | 56 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 11 | 18% |
Other | 7 | 12% |
Student > Ph. D. Student | 7 | 12% |
Professor > Associate Professor | 6 | 10% |
Student > Doctoral Student | 5 | 8% |
Other | 15 | 25% |
Unknown | 9 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 27% |
Psychology | 12 | 20% |
Computer Science | 4 | 7% |
Nursing and Health Professions | 3 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Other | 10 | 17% |
Unknown | 12 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 114. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2021.
All research outputs
#346,014
of 24,334,327 outputs
Outputs from PLOS ONE
#4,973
of 209,793 outputs
Outputs of similar age
#3,009
of 230,542 outputs
Outputs of similar age from PLOS ONE
#108
of 4,611 outputs
Altmetric has tracked 24,334,327 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 209,793 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,542 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 4,611 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.